has vaccine antigen
vaccinated in route
immunizes host
Homo sapiens
spike glycoprotein (SARS-CoV-2)
intranasal route
COVID-19 live, attenuated vaccine
MV-014-212
A SARS-CoV-2 live, attenuated vaccine manufactured by Meissa Vaccines, Inc. that expresses the spike (S) protein of SARS-CoV-2.
NCT04798001
Philip Huang
vaccine